Savara (SVRA) Selling, General & Administrative (2010 - 2026)
Savara (SVRA) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Savara | 1.40 Bn | 1.40 Bn | - | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.57 Mn |
| Dec 31, 2025 | 12.53 Mn |
| Sep 30, 2025 | 9.63 Mn |
| Jun 30, 2025 | 10.66 Mn |
| Mar 31, 2025 | 9.25 Mn |
| Dec 31, 2024 | 7.85 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 5.54 Mn |
| Mar 31, 2024 | 5.64 Mn |
| Dec 31, 2023 | 4.85 Mn |
| Sep 30, 2023 | 4.15 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 3.24 Mn |
| Sep 30, 2022 | 2.38 Mn |
| Jun 30, 2022 | 2.96 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 3.02 Mn |
| Sep 30, 2021 | 3.40 Mn |
| Jun 30, 2021 | 3.15 Mn |